CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 3.72: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
596.64MUSDvs all stocks (USD)
Revenue (TTM)
204.17MUSDvs all stocks (USD)
Profit Margin
-36.25%vs Medical Devices peers
Beta
1.17xvs all stocks
52-Week Change
49.03%vs all stocks
Market Capitalization
596.64MUSDvs all stocks (USD)
Enterprise Value
364.48MUSDvs all stocks (USD)
Forward P/E
23.20xvs Medical Devices peers
Price to Sales (TTM)
2.93xvs Medical Devices peers
Price to Book (MRQ)
1.83xvs Medical Devices peers
Enterprise to Revenue
1.78xvs Medical Devices peers
Enterprise to EBITDA
-10.04xvs Medical Devices peers
Gross Margin
48.16%vs Medical Devices peers
Profit Margin
-36.25%vs Medical Devices peers
Operating Margin
-41.83%vs Medical Devices peers
Return on Assets (TTM)
-5.89%vs Medical Devices peers
Return on Equity (TTM)
-20.93%vs Medical Devices peers
Revenue (TTM)
204.17MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.60USDUpdated Jul 18, 2026Quarterly Revenue Growth
6.50%vs Medical Devices peers
Gross Profit (TTM)
105.56MUSDvs all stocks (USD)
EBITDA (TTM)
-36.30MUSDvs all stocks (USD)
Net Income (TTM)
-74.00MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
6.46%vs Medical Devices peers
Operating Cash Flow (TTM)
-7.30MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
6.41MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
0.00USDFY2025 · Dec 31, 2025Revenue
201.49MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
97.03MUSDFY2025 · Dec 31, 2025Gross Profit
104.46MUSDFY2025 · Dec 31, 2025Operating Income
-40.38MUSDvs all stocks (USD)
Pre-tax Income
-29.84MUSDFY2025 · Dec 31, 2025Income Tax Expense
36.70MUSDFY2025 · Dec 31, 2025Net Income
-66.54MUSDFY2025 · Dec 31, 2025EBIT
-29.37MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-17.39MUSDFY2025 · Dec 31, 2025Research & Development
36.47MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
108.38MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
2.22MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
474.00KUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.5200USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.5200USDFY2025 · Dec 31, 2025Basic Shares Outstanding
127.75MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
127.75MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-66.54MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00USDFY2025 · Dec 31, 2025Operating Cash Flow
-2.86MUSDFY2025 · Dec 31, 2025Free Cash Flow
-6.69MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
90.85MUSDFY2025 · Dec 31, 2025Income Tax Paid
2.16MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-66.54MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
11.97MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
33.56MUSDFY2025 · Dec 31, 2025Stock-based Compensation
24.59MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-328.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
368.00KUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
448.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-6.92MUSDFY2025 · Dec 31, 2025Capital Expenditures
-3.83MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-106.00KUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Purchase of Investments
-278.15MUSDFY2025 · Dec 31, 2025Sale of Investments
292.21MUSDFY2025 · Dec 31, 2025Other Investing Activity
-1.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
10.22MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-4.75MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
5.58MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-15.07MUSDFY2025 · Dec 31, 2025Other Financing Charges
-669.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-14.91MUSDFY2025 · Dec 31, 2025Shares Outstanding
129.14MSharesUpdated Jul 18, 2026Float Shares
96.58MSharesUpdated Jul 18, 2026Shares Short
3.51MSharesUpdated Jul 18, 2026Short Ratio
1.52daysvs all stocks
Short % of Shares Outstanding
3.44%vs all stocks
% Held by Insiders
8.42%vs all stocks
% Held by Institutions
67.59%vs all stocks
Total Cash (MRQ)
262.22MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.03USDUpdated Jul 18, 2026Total Debt (MRQ)
27.48MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0839xvs Medical Devices peers
Current Ratio (MRQ)
4.69xvs Medical Devices peers
Book Value per Share (MRQ)
2.54USDUpdated Jul 18, 2026Total Assets
461.54MUSDvs all stocks (USD)
Total Current Assets
392.00MUSDFY2025 · Dec 31, 2025Total Liabilities
119.80MUSDFY2025 · Dec 31, 2025Total Non-current Assets
69.55MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
42.00MUSDFY2025 · Dec 31, 2025Total Current Liabilities
77.80MUSDFY2025 · Dec 31, 2025Cash
28.98MUSDFY2025 · Dec 31, 2025Cash Equivalents
61.87MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
90.85MUSDFY2025 · Dec 31, 2025Other Short-term Investments
170.68MUSDFY2025 · Dec 31, 2025Accounts Receivable
62.51MUSDFY2025 · Dec 31, 2025Inventory
48.43MUSDFY2025 · Dec 31, 2025Accounts Payable
6.41MUSDFY2025 · Dec 31, 2025Short-term Debt
9.18MUSDFY2025 · Dec 31, 2025Deferred Revenue
29.57MUSDFY2025 · Dec 31, 2025Other Current Liabilities
2.95MUSDFY2025 · Dec 31, 2025Long-term Debt
14.57MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
9.09MUSDFY2025 · Dec 31, 2025Common Stock (Book)
129.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-101.74MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
341.74MUSDvs all stocks (USD)
52-Week Low
3.09USDUpdated Jul 18, 202652-Week High
6.18USDUpdated Jul 18, 202652-Week Change
49.03%vs all stocks
Beta
1.17xvs all stocks
50-Day MA
4.20USDUpdated Jul 18, 2026200-Day MA
4.53USDUpdated Jul 18, 2026Avg 10-Day Volume
904.75KSharesUpdated Jul 18, 2026Avg 30-Day Volume
1.90MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-0.5800USDUpdated Jul 18, 2026Other Income / Expense
8.80MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.48Profit Margin: -0.36
Financial Health
Altman Z-Score 3.72: safe zoneNotable
Altman Z-Score: 3.72
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Shanghai Xiao Feng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Starry Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
FDC Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Ningbo David Medical Device Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Bohui Innovation Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Nanjing Hicin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
BrainsWay Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nuvectis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Seers Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Clarity Pharmaceuticals Ltd
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Chipotle Mexican Grill, Inc.
1 interpretationRevenue Growing With Receivables Growing
Copart Inc.
1 interpretationRevenue Growing With Receivables Growing
Hangzhou Todaytec Digital Co., Ltd.
1 interpretationRevenue Growing With Receivables Growing